InMode Ltd. (INMD) News

InMode Ltd. (INMD): $35.71

0.31 (+0.88%)

POWR Rating

Component Grades













Filter INMD News Items

INMD News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

INMD News Highlights

  • INMD's 30 day story count now stands at 11.
  • Over the past 25 days, the trend for INMD's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • SKIN, EYE and BODY are the most mentioned tickers in articles about INMD.

Latest INMD News From Around the Web

Below are the latest news stories about INMODE LTD that investors may wish to consider to help them evaluate INMD as an investment opportunity.

2 No-Brainer Stocks to Buy Now That Could Soar in 2023

As the year winds down, investors may be looking forward to 2023 and hoping for a better year in the stock market. Part of this growth is due to sales of consumables, which increased 53% year over year, outpacing revenue growth.

Yahoo | November 26, 2022

InMode Receives Health Canada Certification of Forma-I for Dry Eye Disease Due to Meibomian Gland Dysfunction

InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is proud to announce the Health Canada license of the Forma-I to address the symptoms of dry eye disease due to Meibomian gland dysfunction (MGD). Forma-I is intended for use in the periorbital area and eyelids and relieves inflammation of meibomian glands and eye irritation.

Yahoo | November 25, 2022

7 Stocks on the Perfect 10 List

Companies that have strong quality, value, or growth grades are the stocks to buy once markets recognize their business potential.

Chris Lau on InvestorPlace | November 23, 2022

Is InMode Stock a Buy Now?

InMode (NASDAQ: INMD) is a medical device company that provides its consumers with a wide range of treatments to help with contouring skin, treating acne, removing hair, and other aesthetic issues. InMode operates in an area of healthcare -- aesthetics -- that is proving to be strong amid inflation; in its most recent quarter (the period ended Sept. 30), the company reported revenue of $121.1 million, which was up 29% year over year.

Yahoo | November 23, 2022

If You Invested $5,000 In InMode Stock In 2020, Here's How Much Money You'd Have Today

InMode (NASDAQ: INMD) is a growth stock unlike any other, and it's also one of my biggest holdings. This medical aesthetics company hails from Israel, and it makes technologies that enable minimally invasive beauty treatments, ranging from skin tightening to body contouring. Investing in InMode in early 2020 was a smart move.

Yahoo | November 20, 2022

InMode Stock Shows Improved Technical Strength; Hits Key Technical Threshold

A Relative Strength Rating upgrade for InMode shows improving technical performance. Will it continue?

Yahoo | November 16, 2022

Up 58% in 6 Months, Is InMode Stock Still a Bargain Buy?

On that note, shares of the Israeli medical aesthetics company InMode (NASDAQ: INMD) are up by more than 58% in the last six months, despite the market being flat and concerns about rising interest rates ravaging similar growth stocks. If you're looking for exposure to growth at an acceptable price, there's reason to believe you'll still be getting a decent deal with InMode shares. InMode's claim to fame is its minimally invasive devices for performing skin-tightening and fat-burning beauty treatments that aren't as burdensome for patients as other approaches like plastic surgery.

Yahoo | November 16, 2022

1 Growth Stock Down 65.8% That's a Bargain Right Now

The Nasdaq Composite index has collapsed by about 33% this year. Growth stocks across the board have been getting hit hard even though not all of them deserved a severe market beating. Cosmetic device maker InMode (NASDAQ: INMD) is a former high-flying growth stock that has been hammered 65.8% from the peak it reached in 2021.

Yahoo | November 12, 2022

Get Into This Growth Stock for 2023 and Beyond

The stock of aesthetic surgical company InMode (NASDAQ: INMD) has fallen 66% from its high, underperforming the broader market over the past year. Bear markets often mean relentless selling, and Wall Street doesn't always get it right. The numbers show that InMode is more than just fine -- and the stock could be a market beater when growth stocks come back into favor with investors.

Yahoo | November 10, 2022

2 Beaten-Down Growth Stocks You Can Confidently Buy Right Now

The Nasdaq Composite index, which contains heaps of growth stocks is down 33% in 2022 and there could be more pain ahead. On Nov. 2, the Federal Reserve raised the primary credit rate to 4% from nearly nothing at the beginning of the year. With capital a lot harder to come by, capital-hungry businesses in a high-growth phase could stagnate.

Yahoo | November 6, 2022

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5303 seconds.